Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024 16:05 ET
|
Immuneering Corporation
Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
March 28, 2024 08:05 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM...
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
March 25, 2024 09:05 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced the publication of new data analysis from a long-term Early Access Program (“EAP”)...
Global Generic Oncology Sterile Injectable Market Set for Rapid Growth, Forecast 2024: New Research Report
March 22, 2024 10:38 ET
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Generic Oncology Sterile Injectable Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global generic...
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
March 22, 2024 08:55 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s...
Community Oncology Services Global Market Report 2024
March 21, 2024 18:54 ET
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Community Oncology Services Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The community oncology services...
Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction
March 20, 2024 11:13 ET
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
March 15, 2024 08:45 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., March 15, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that it will present at the Virtual Investor Lunch Break: The AIM...
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024 08:30 ET
|
FN Media Group LLC
PALM BEACH, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer...
AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
February 29, 2024 08:45 ET
|
AIM ImmunoTech Inc.
Company continues progress across Ampligen® clinical development programs Growing body of promising data demonstrates Ampligen’s potential to address multiple high-value indications OCALA, Fla.,...